Health Canada has updated its website, indicating that it has awarded the 44th ACMPR license to Ontario-based First Access Medical, which is owned by Beleave, Inc. (CSE: BE) (OTC: BLEVF). The company’s 14,500 sq. ft. facility in Hamilton is capable of producing 550K grams of dried cannabis per year, and it will be adding a 60K sq. ft. hybrid greenhouse, according to its recent corporate presentation.
The approval follows a pre-license inspection more than two months ago. Beleave, which was halted before trading opened today, has increased dramatically over the past year and has a fully-diluted market cap of C$76mm based upon the close of C$2.23 on May 18th.
Based in Houston, Alan leverages his experience as founder of online community 420 Investor, the first and still largest due diligence platform focused on the publicly-traded stocks in the cannabis industry. With his extensive network in the cannabis community, Alan continues to find new ways to connect the industry and facilitate its sustainable growth. At New Cannabis Ventures, he is responsible for content development and strategic alliances. Before shifting his focus to the cannabis industry in early 2013, Alan, who began his career on Wall Street in 1986, worked as an independent research analyst following over two decades in research and portfolio management. A prolific writer, with over 650 articles published since 2007 at Seeking Alpha, where he has 70,000 followers, Alan is a frequent speaker at industry conferences and a frequent source to the media, including the NY Times, the Wall Street Journal, Fox Business, and Bloomberg TV. Contact Alan: Twitter | Facebook | LinkedIn | Email